Consensus Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Real-time Estimate Cboe BZX Other stock markets 02:52:49 2024-04-29 pm EDT			5-day change	1st Jan Change
278.8 ^USD	+1.02%		-0.45%	-13.63%

03:41pm	RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474	MT
Apr. 26	Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	CI

Evolution of the average Target Price on Bio-Rad Laboratories, Inc.

Price target over the last 5 years

History of analyst recommendation changes

3d31c6eec08e2df7dfb541d30efb1e2.Pg2noM8zA_wJEYnTOHrfOt4qYevEBpXJLZo67SScrjo.E2jo0atlb556X7-FVS24CahFB5-8SN2dYNlrl37kyWBNefDvrXttimAl4g~67888a3e8997864e237fe70cfa5d59b4

Analyst Recommendations on Bio-Rad Laboratories, Inc.

RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474	09:41am	MT
Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322	Apr. 15	MT
RBC Trims Price Target on Bio-Rad Laboratories to $474 From $480, Keeps Outperform Rating	Apr. 08	MT
Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $365 From $400	Apr. 03	MT
UBS Adjusts Bio-Rad Laboratories Price Target to $420 From $395, Maintains Buy Rating	Feb. 16	MT
RBC Trims Price Target on Bio-Rad Laboratories to $480 From $484, Keeps Outperform Rating	Feb. 16	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
UBS Initiates Coverage on Bio-Rad Laboratories With Buy Rating, $395 Price Target	Dec. 07	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $482 From $513, Notes 'Near-Term Headwinds,' Keeps Outperform Rating	23-10-27	MT
ANALYST RECOMMENDATIONS : Amazon, Comcast, Intel, Merck, Roblox...	23-10-27
Wells Fargo Adjusts Price Target on Bio-Rad Laboratories to $525 From $550, Keeps Overweight Rating	23-08-07	MT
Wells Fargo Lowers Price Target on Bio-Rad Laboratories to $525 From $550, Maintains Overweight Rating	23-08-07	MT
Credit Suisse Adjusts Bio-Rad Laboratories' Price Target to $550 From $580, Keeps Outperform Rating	23-08-04	MT
RBC Raises Price Target on Bio-Rad Laboratories to $524 From $522, Maintains Outperform Rating	23-08-04	MT
RBC Cuts Bio-Rad Laboratories' Price Target to $522 From $536, Keeps Outperform Rating	23-07-17	MT
Wells Fargo Initiates Bio-Rad Laboratories With Overweight Rating, $550 Price Target	23-06-16	MT
ANALYST RECOMMENDATIONS : Adobe, Wells Fargo, American Express...	23-06-16
RBC Boosts Price Target on Bio-Rad Laboratories to $536 From $531, Maintains Outperform Rating	23-05-15	MT
Citigroup Adjusts Bio-Rad Laboratories' Price Target to $525 From $550, Keeps Buy Rating	23-05-08	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $531 From $582 After Guidance Cut But Sees Buying Opportunity After Stock Drop; Outperform Kept	23-05-08	MT
Credit Suisse Cuts Bio-Rad Laboratories' PT to $580 From $680 After Lower-Than-Expected Q1 Results, Keeps Outperform Rating	23-05-05	MT
RBC Boosts Price Target on Bio-Rad Laboratories to $582 From $579, Maintains Outperform Rating	23-04-14	MT
RBC Raises Price Target on Bio-Rad Laboratories to $582 From $579, Maintains Outperform Rating	23-04-13	MT
Credit Suisse Adjusts Price Target on Bio-Rad Laboratories to $680 From $640, Maintains Outperform Rating	23-02-17	MT
RBC Lifts Price Target on Bio-Rad Laboratories to $579 From $571, Says 'Strong' Results, Outlook 'Not Reflected in Shares,' Keeps Outperform Rating	23-02-17	MT